Back to top

Analyst Blog

Patterson Companies Inc. (PDCO - Analyst Report), a leading distributor of dental, veterinarian and rehabilitation medical supplies, posted first-quarter fiscal 2012 (ended July 30) earnings per share of 42 cents, below the Zacks Consensus Estimate of 44 cents and the year-ago earnings of 45 cents.

Net income clipped 9.9% year over year to $48.6 million, hit by expenses associated with the Minnesota-based company’s Employee Stock Ownership Plan (“ESOP”). Excluding the impact, the company reported earnings of 45 cents a share.


Revenues rose 6% year over year on a comparable basis to roughly $847.4 million, yet missed the Zacks Consensus Estimate of $866 million. Comparable basis sales exclude the impact of the benefit from an additional week a year ago which made fiscal 2011 a 53-week year.

However, on a reported basis, sales fell 0.3% year over year. Patterson witnessed growth across the board in the quarter on a comparable basis.

Segment Analysis

By business segment, revenues from Patterson’s core Dental Supply division rose roughly 4% year over year on a comparable basis to $533.4 million, driven by higher dental equipment and software sales (up 7%).

Dental equipment sales were boosted by healthy sales from Patterson’s CEREC dental restoration systems and digital imaging products. Consumable and printed product sales grew 2% on a comparable basis. The dental market continues to be impacted by a soft economy.

Revenues from the Webster Veterinary Supply unit climbed 8% year over year on a comparable basis to roughly $179.6 million, boosted by solid sales of consumable supplies and veterinary equipment and software.

Separately, the division announced the purchase of veterinary distributor  -- American Veterinary Supply Corporation serving roughly 2,000 veterinary practices and hospitals in the New York metropolitan area with sales of $25 million. Financial and other terms of the deal were not disclosed.

Patterson’s Rehabilitation Supply (“Patterson Medical”) business remains on a growth track with sales surging 12% year over year (on a comparable basis) to roughly $134.5 million, buoyed by DCC Healthcare acquisition and favorable foreign exchange swings.

The division continues to gain market share despite a changing regulatory environment in North America and international markets. The company has completed the integration of DCC Healthcare.


Gross margin for the quarter trimmed modestly to 32.8% from 33% a year ago. Operating margin fell to 9.7% from 10.5% a year ago. Operating expenses (as a percentage of sales) rose to 23.2% from 22.5%.

Financial Condition

Patterson ended the quarter with cash and short-term investments of roughly $373.8 million, up 25% year over year. Long-term debt remained flat year over year and sequentially at $525 million. The company repurchased nearly 2 million shares during the quarter.


Patterson has backed its earnings per share forecast for fiscal 2012 which is still expected between $1.90 and $2.00. The current corresponding Zacks Consensus Estimate is $1.96. Patterson also expects that the total impact of ESOP expense in fiscal 2012 to be 12 cents a share.

Patterson provides a wide range of consumable supplies, equipment and software and value-added services to its customers. The company competes head-to-head with Henry Schein Inc (HSIC - Analyst Report) in the dental market. We currently have a Neutral recommendation on the stock, supported by a short-term Zacks #3 Rank (Hold).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UTD THERAPE… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%